You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港A醫藥股底部大反攻!A股現漲停潮
格隆匯9月6日丨港A兩地醫藥股今日迎來久違的大漲行情,A股醫藥板塊現漲停潮。新華醫療、通策醫療、精華製藥、昭衍新藥、凱萊英、天壇生物、健民集團、廣譽遠、中關村、亞寶藥業漲停,美迪西、鍵凱科技、藥石科技、博騰股份、歐普康視、愛爾眼科、邁瑞醫療等漲幅均在10%以上。港股四環醫藥、泰格醫藥漲近10%,朗生醫藥漲近8%,康龍化成、上海醫藥漲超4%。分析人士認為,醫藥板塊最佳買點或已出現,站在目前時間點,醫藥生物是一條長期趨勢向上的核心賽道,在市場此輪迴調後,醫藥板塊估值水平重回可投區間。中信證券最新報吿稱,9月是佈局A股四季度行情的最佳窗口,建議在成長製造和價值消費間保持均衡配置,並考慮左側佈局消費醫藥等板塊。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.